Hinge Health CEO Daniel Perez sells over $410k in company stock

On October 6, 2026, Daniel Antonio Perez, the CEO and co-founder of Hinge Health Inc. (NASDAQ:HNGE), sold 4,100 shares of the company's Class A Common Stock. The sale was executed under a Rule 10b5-1 trading plan, adopted by Perez and his spouse on June 11, 2026. The shares were sold within a narrow price range of $100.05 to $100.26, with an average cost of $100.1978 per share.

This transaction took place as the stock was trading near its 52-week high of $100.36, following a significant increase of 156% over the past six months. Prior to selling, Perez had acquired 4,100 shares of Class A Common Stock, which were subsequently converted from Class B Common Stock. As a result of these transactions, Perez currently holds no Class A Common Stock, retaining 9,774,572 shares of Class B Common Stock.

His spouse indirectly owns 35,470 shares of Class A Common Stock and 208,445 shares of Class B Common Stock, excluding 3,777,002 performance-based restricted stock units held by Perez. The insider sale occurs as Hinge Health, valued at $7.9 billion, is reportedly overvalued according to InvestingPro analysis. Analysts have shown positive sentiment towards the company, with Truist Securities raising its price target to $112, citing improved financial projections following its second-quarter earnings and a pending acquisition.

Stifel increased its price target to $115, while BofA Securities initiated coverage with a Buy rating and a price target of $110.